Welcome to our dedicated page for AmerisourceBergen Corporation news (Ticker: abc), a resource for investors and traders seeking the latest updates and insights on AmerisourceBergen Corporation stock.
Cencora, Inc. (NYSE: COR), formerly known as AmerisourceBergen Corporation, is a leading global pharmaceutical solutions organization dedicated to improving the lives of people and animals worldwide. With a unified identity and vision under the new name, Cencora connects pharmaceutical innovators, care providers, pharmacies, and patients to ensure the seamless and reliable delivery of vital therapies and healthcare products.
Headquartered in Conshohocken, Pennsylvania, Cencora boasts a comprehensive portfolio of services across the pharmaceutical value chain. The company is renowned for its robust pharmaceutical distribution network, specialty logistics, and biopharma services, ensuring medications reach their destinations efficiently and safely. Cencora's extensive reach is evidenced by its operations in over 50 countries, supported by a team of more than 46,000 dedicated employees.
Cencora's commitment to innovation is further highlighted through initiatives like Cencora Ventures, the company's corporate venture fund dedicated to fostering healthcare advancements. Additionally, the Cencora Impact Foundation underscores the company's dedication to social responsibility, with a recent $5 million donation to support global healthcare initiatives, including a significant grant to UNICEF Health Fund.
Financially, Cencora is a powerhouse with more than $200 billion in annual revenue, ranking #11 on the Fortune 500 and #24 on the Global Fortune 500. The company's strategic investments, such as the acquisition of OneOncology and PharmaLex, showcase its focus on expanding its specialty and global commercialization services. Cencora's recent name change reflects its bold vision and purpose-driven approach to creating healthier futures, unifying its global presence under one cohesive brand.
AmerisourceBergen (ABC), Cardinal Health (CAH), and McKesson (MCK) announced a proposed settlement addressing the majority of opioid lawsuits from state and local entities. The settlement, contingent on participation from states and political subdivisions, could provide up to $21 billion over 18 years. Contributions include $6.4 billion from each AmerisourceBergen and Cardinal Health, and $7.9 billion from McKesson. The settlement is seen as a step towards resolving opioid claims, with strong legal defenses maintained in pending litigation if not finalized.
AmerisourceBergen, Cardinal Health, and McKesson have agreed to pay up to $1.179 billion to settle opioid-related claims with New York and its subdivisions, including Nassau and Suffolk Counties. This settlement is part of ongoing negotiations for a broader resolution concerning claims from various states. The distributors will receive claims dismissal in exchange for the settlement amount and associated legal fees. While disputing the allegations, the companies view this as a step toward focusing resources on safe medication delivery and supporting affected communities.
AmerisourceBergen Corporation (NYSE: ABC) will release its Third Quarter Fiscal 2021 results on August 4, 2021, prior to NYSE trading. A conference call at 8:30 a.m. ET will feature Steven H. Collis, CEO, and James F. Cleary, CFO, discussing these results. Investors can access the call via dial-in or through a live webcast on the company's website. Replays will be available shortly after the call and for a limited time. AmerisourceBergen is a leading healthcare company ranked 8th on the Fortune 500, generating over $200 billion in annual revenue.
AmerisourceBergen Corporation (NYSE: ABC) will participate in two upcoming virtual investor conferences. The first is the Goldman Sachs 42nd Annual Global Healthcare Conference from June 8-11, 2021, followed by the Baird Healthcare ESG Symposium on June 17, 2021. Interested investors can check the company's website for updates on live webcasts and replay information. AmerisourceBergen is a leading global healthcare company, ranked #8 on the Fortune 500, with over $200 billion in annual revenue and a commitment to improving health globally.
AmerisourceBergen Corporation (NYSE: ABC) has finalized the acquisition of Walgreens Boots Alliance's Alliance Healthcare businesses for $6.275 billion in cash, plus 2 million shares of common stock. This acquisition enhances AmerisourceBergen's pharmaceutical distribution capabilities and global manufacturer services. The company has updated its fiscal 2021 guidance, projecting revenues of at least $210 billion and adjusted earnings per share (EPS) between $8.90 and $9.10. The acquisition is expected to drive growth and synergies, marking a significant strategic move for AmerisourceBergen.
AmerisourceBergen Corporation (NYSE: ABC) reported a revenue increase of 3.7% year-over-year, reaching $49.2 billion for Q2 FY2021. Diluted EPS dropped to $2.10 compared to $4.64 in Q2 FY2020. However, adjusted diluted EPS rose by 5.4% to $2.53. The company updated its adjusted EPS guidance for FY2021, raising it to a range of $8.45 to $8.60, reflecting a growth of 7% to 9%.
AmerisourceBergen Corporation (NYSE: ABC) plans to release its Second Quarter Fiscal 2021 results on May 5, 2021, prior to NYSE trading. The conference call to discuss these results will occur at 8:30 a.m. ET on the same day, featuring CEO Steven H. Collis and CFO James F. Cleary. Interested parties can join via a dial-in number or a live webcast available on the company's investor relations website. Replays will be accessible for one year via the webcast and for seven days via telephone.
AmerisourceBergen is recognized as a leading global healthcare firm with substantial annual revenue.
AmerisourceBergen (NYSE: ABC) has successfully closed a public offering totaling $2.525 billion, comprising $1.525 billion in 0.737% Senior Notes due March 15, 2023, and $1 billion in 2.700% Senior Notes due March 15, 2031. Proceeds will fund the acquisition of Walgreens Boots Alliance's Alliance Healthcare businesses and cover related expenses. The offering was conducted under a shelf registration statement filed with the SEC on November 20, 2018.
AmerisourceBergen Corporation (NYSE: ABC) has priced $1.525 billion in 0.737% Senior Notes due March 15, 2023, and $1 billion in 2.700% Senior Notes due March 15, 2031. The offering, underwritten by J.P. Morgan and others, is set to close on March 30, 2021. Proceeds will finance the acquisition of Walgreens Boots Alliance’s Alliance Healthcare businesses, along with related fees and general corporate purposes. This initiative highlights ABC's strategic growth through targeted acquisitions and financing.
AmerisourceBergen Corporation (NYSE: ABC) reported a 9.7% increase in revenue year-over-year, reaching $52.5 billion for Q1 of fiscal year 2021 ending December 31, 2020. The company's diluted earnings per share (EPS) was reported at $1.81, up from $0.90 a year earlier. Adjusted diluted EPS rose 24% to $2.18. The Company has also updated its outlook for fiscal year 2021, signaling potential growth ahead.
FAQ
What is the market cap of AmerisourceBergen Corporation (abc)?
What is Cencora, Inc.?
Why did AmerisourceBergen change its name to Cencora?
What services does Cencora provide?
What recent strategic investments has Cencora made?
How does Cencora contribute to social responsibility?
What is Cencora Ventures?
How large is Cencora's workforce?
What is Cencora's financial standing?
When did Cencora begin trading under the new ticker symbol?
What is the purpose of the Cencora Healthier Futures Grant Program?
